{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:01:51Z","timestamp":1777896111300,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006588","name":"Ministarstvo Znanosti, Obrazovanja i Sporta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ejphar.2019.172593","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T21:59:19Z","timestamp":1565301559000},"page":"172593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable gastric pentadecapeptide BPC 157, L-arginine, L-NAME"],"prefix":"10.1016","volume":"861","author":[{"given":"Mario","family":"Sucic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kresimir","family":"Luetic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Jandric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domagoj","family":"Drmic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita Zenko","family":"Sever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lovorka Batelja","family":"Vuletic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeljka Belosic","family":"Halle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Strinic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Kokot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranka Serventi","family":"Seiwerth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Zoricic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alenka Boban","family":"Blagaic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Seiwerth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Predrag","family":"Sikiric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172593_bib1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.eururo.2010.10.035","article-title":"Effects of nitric oxide on the primary bladder afferent activities of the rat with and without intravesical acrolein treatment","volume":"59","author":"Aizawa","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2019.172593_bib2","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.3748\/wjg.v24.i47.5366","article-title":"Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine","volume":"24","author":"Amic","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2019.172593_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s002100000371","article-title":"Nitric oxide synthases and cyclophosphamide-induced cystitis in rats","volume":"363","author":"Alfieri","year":"2001","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172593_bib4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1152\/physrev.00038.2003","article-title":"Urinary bladder contraction and relaxation: physiology and pathophysiology","volume":"84","author":"Andersson","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2019.172593_bib5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jjco\/hyf035","article-title":"Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer","volume":"32","author":"Bakan","year":"2002","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2019.172593_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.lfs.2016.02.029","article-title":"Stable gastric pentadecapeptide BPC 157 heals rectovaginal fistula in rats","volume":"148","author":"Baric","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2019.172593_bib7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10787-017-0358-8","article-title":"Class side effects: decreased pressure in the lower oesophageal and the pyloric sphincters after the administration of dopamine antagonists, neuroleptics, anti-emetics, l-NAME, pentadecapeptide BPC 157 and l-arginine","volume":"25","author":"Belosic Halle","year":"2017","journal-title":"Inflammopharmacology"},{"issue":"Suppl. 7","key":"10.1016\/j.ejphar.2019.172593_bib8","first-page":"191","article-title":"Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing","volume":"60","author":"Brcic","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172593_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejphar.2012.11.055","article-title":"Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy","volume":"701","author":"Cesarec","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172593_bib10","doi-asserted-by":"crossref","first-page":"19066","DOI":"10.3390\/molecules191119066","article-title":"Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts","volume":"19","author":"Chang","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2019.172593_bib11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1152\/japplphysiol.00945.2010","article-title":"The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration","volume":"110","author":"Chang","year":"2011","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2019.172593_bib12","first-page":"565","article-title":"Prophylactic intravesical instillation of epinephrine prevents cyclophosphamide-induced hemorrhagic cystitis in rats","volume":"232","author":"Chow","year":"2007","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2019.172593_bib13","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.3748\/wjg.v22.i41.9127","article-title":"Esophagogastric anastomosis in rats: improved healing by BPC 157 and L-arginine, aggravated by L-NAME","volume":"22","author":"Djakovic","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2019.172593_bib14","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.3748\/wjg.v23.i29.5304","article-title":"Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME","volume":"23","author":"Drmic","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2019.172593_bib15","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.3748\/wjg.v24.i48.5462","article-title":"Counteraction of perforated cecum lesions in rats: effects of pentadecapeptide BPC 157, L-NAME and L-arginine","volume":"24","author":"Drmic","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2019.172593_bib16","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.3748\/wjg.v23.i48.8465","article-title":"Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: new insights","volume":"23","author":"Duzel","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2019.172593_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2016.02.038","article-title":"Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula","volume":"780","author":"Grgic","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172593_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s00441-019-03016-8","article-title":"Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing","author":"Gwyer","year":"2019","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejphar.2019.172593_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00109-016-1488-y","article-title":"Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation","volume":"95","author":"Hsieh","year":"2017","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ejphar.2019.172593_bib20","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.2147\/DDDT.S82030","article-title":"Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro","volume":"9","author":"Huang","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2019.172593_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.12659\/MSMBR.883828","article-title":"Salutary effect of gastric pentadecapeptide BPC 157 in two different stress urinary incontinence models in female rats","volume":"19","author":"Jandric","year":"2013","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"10.1016\/j.ejphar.2019.172593_bib22","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2174\/1381612824666180614082950","article-title":"BPC157 as potential agent rescuing from cancer cachexia","volume":"24","author":"Kang","year":"2018","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2019.172593_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejphar.2015.12.016","article-title":"NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced miosis: reversal by the pentadecapeptide BPC 157 in rats and Guinea pigs","volume":"771","author":"Kokot","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172593_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162590","article-title":"Effects of diclofenac, L-NAME, L-arginine, and pentadecapeptide BPC 157 on gastrointestinal, liver, and brain lesions, failed anastomosis, and intestinal adaptation deterioration in 24 hour-short-bowel rats","volume":"11","author":"Lojo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.172593_bib25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10787-017-0330-7","article-title":"Cyclophosphamide induced stomach and duodenal lesions as a NO-system disturbance in rats: l-NAME, l-arginine, stable gastric pentadecapeptide BPC 157","volume":"25","author":"Luetic","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2019.172593_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.etap.2015.07.013","article-title":"Protective effect of N-acetylcysteine on cyclophosphamide-induced cardiotoxicity in rats","volume":"40","author":"Mansour","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172593_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/09629359791875","article-title":"Nitric oxide function in atherosclerosis","volume":"6","author":"Matthys","year":"1997","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejphar.2019.172593_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: physiology, pathophysiology, and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2019.172593_bib29","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00595-007-3706-2","article-title":"Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat","volume":"38","author":"Novinscak","year":"2008","journal-title":"Surg. Today"},{"key":"10.1016\/j.ejphar.2019.172593_bib30","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/S0022-5347(05)68161-X","article-title":"Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis","volume":"162","author":"Ozawa","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2019.172593_bib31","first-page":"BR81","article-title":"Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application","volume":"16","author":"Pevec","year":"2010","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ejphar.2019.172593_bib32","doi-asserted-by":"crossref","first-page":"A14","DOI":"10.1097\/00008390-200408000-00050","article-title":"BPC 157 inhibits cell growth and VEGF signaling via MAPK pathway in human melanoma cell line","volume":"14","author":"Radeljak","year":"2004","journal-title":"Melanoma Res."},{"key":"10.1016\/j.ejphar.2019.172593_bib33","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0022-5347(05)65134-8","article-title":"Tumor necrosis factor-alpha and interleukin-1beta mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice","volume":"167","author":"Ribeiro","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2019.172593_bib34","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2174\/13816128113199990421","article-title":"BPC 157 and blood vessels","volume":"20","author":"Seiwerth","year":"2014","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2019.172593_bib35","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.2174\/1381612824666180712110447","article-title":"BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing","volume":"24","author":"Seiwerth","year":"2018","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2019.172593_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2019.01.030","article-title":"Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation","volume":"847","author":"Sever","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172593_bib37","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.2174\/1381612824666180608101119","article-title":"Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Vascular recruitment and gastrointestinal tract healing","volume":"24","author":"Sikiric","year":"2018","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2019.172593_bib38","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2174\/138161210790945977","article-title":"Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator","volume":"16","author":"Sikiric","year":"2010","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2019.172593_bib39","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.2174\/1381612823666170220163219","article-title":"Stress in gastrointestinal tract and stable gastric pentadecapeptide BPC 157. Finally, do we have a solution?","volume":"23","author":"Sikiric","year":"2017","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2019.172593_bib40","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2174\/1570159X13666160502153022","article-title":"Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications","volume":"14","author":"Sikiric","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2019.172593_bib41","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2174\/13816128113190990411","article-title":"Stable gastric pentadecapeptide BPC 157-NO-system relation","volume":"20","author":"Sikiric","year":"2014","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2019.172593_bib42","first-page":"76","article-title":"Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157","volume":"19","author":"Sikiric","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2019.172593_bib43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/092986712803414015","article-title":"Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157","volume":"19","author":"Sikiric","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.172593_bib44","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2174\/138161211796196954","article-title":"Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract","volume":"17","author":"Sikiric","year":"2011","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2019.172593_bib45","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0928-4257(99)00123-0","article-title":"The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation","volume":"93","author":"Sikiric","year":"1999","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/j.ejphar.2019.172593_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(97)01033-9","article-title":"The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure","volume":"332","author":"Sikiri\u0107","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172593_bib47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0928-4257(93)90038-U","article-title":"A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC","volume":"87","author":"Sikiri\u0107","year":"1993","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/j.ejphar.2019.172593_bib48","first-page":"247","article-title":"Involvement of nitric oxide in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis","volume":"150","author":"Souza-Fiho","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2019.172593_bib49","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/jor.20089","article-title":"Effective therapy of transected quadriceps muscle in rat: gastric pentadecapeptide BPC 157","volume":"24","author":"Staresinic","year":"2006","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.ejphar.2019.172593_bib50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejphar.2007.05.072","article-title":"Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression","volume":"570","author":"Tkal\u010devi\u0107","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172593_bib51","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0016-5085(95)27355-7","article-title":"Digestion of h-EGF, h-TGF alpha, and BPC-15 in human gastric juice","volume":"108","author":"Veljaca","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2019.172593_bib52","first-page":"265","article-title":"Nonsteroidal anti-inflammatory drugs-induced failure of lower esophageal and pyloric sphincter and counteraction of sphincters failure with stable gastric pentadecapeptide BPC 157 in rats","volume":"68","author":"Vitaic","year":"2017","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172593_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.vph.2018.02.010","article-title":"Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157","volume":"106","author":"Vukojevi\u0107","year":"2018","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172593_bib54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12264-018-0269-8","article-title":"Cytoprotective mechanism of the novel gastric peptide BPC157 in gastrointestinal tract and cultured enteric neurons and glial cells","volume":"35","author":"Wang","year":"2019","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ejphar.2019.172593_bib55","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1749-6632.1992.tb39755.x","article-title":"Biosynthesis and role of the endothelium-derived vasodilator, nitric oxide, in the gastric mucosa","volume":"664","author":"Whittle","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2019.172593_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(01)00846-9","article-title":"Expression of inducible nitric oxide synthase in primary culture of rat bladder smooth muscle cells by plasma from cyclophosphamide-treated rats","volume":"416","author":"Xu","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172593_bib57","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3748\/wjg.v10.i7.1032","article-title":"Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats","volume":"10","author":"Xue","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2019.172593_bib58","first-page":"337","article-title":"Mechanism of acrolein-induced vascular toxicity","volume":"56","author":"Yousefipour","year":"2005","journal-title":"J. Physiol. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991930545X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991930545X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:29:51Z","timestamp":1757975391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991930545X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":58,"alternative-id":["S001429991930545X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172593","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable gastric pentadecapeptide BPC 157, L-arginine, L-NAME","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172593"}}